이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Apellis Pharmaceuticals 소유권
주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?
최근 내부자 거래
날짜 | 가치 | 이름 | 엔티티 | 역할 | 공유 | 최대 가격 |
---|---|---|---|---|---|---|
19 Mar 24 | SellUS$1,068,161 | Epidarex Capital | Company | 18,681 | US$57.18 | |
18 Mar 24 | SellUS$564,050 | Mark Delong | Individual | 9,913 | US$56.90 | |
15 Mar 24 | SellUS$10,389 | James Chopas | Individual | 184 | US$56.46 | |
13 Mar 24 | SellUS$645,838 | Nur Nicholson | Individual | 11,220 | US$58.13 | |
12 Feb 24 | SellUS$40,457 | Mark Delong | Individual | 597 | US$67.77 | |
12 Feb 24 | SellUS$96,974 | Timothy Sullivan | Individual | 1,431 | US$67.77 | |
12 Feb 24 | SellUS$77,796 | Adam Townsend | Individual | 1,148 | US$67.77 | |
12 Feb 24 | SellUS$52,926 | David Watson | Individual | 781 | US$67.77 | |
12 Feb 24 | SellUS$268,492 | Cedric Francois | Individual | 3,962 | US$67.77 | |
12 Feb 24 | SellUS$77,796 | Pascal Deschatelets | Individual | 1,148 | US$67.77 | |
29 Jan 24 | SellUS$23,539 | Mark Delong | Individual | 367 | US$64.14 | |
29 Jan 24 | SellUS$17,895 | Jeffrey Eisele | Individual | 279 | US$64.14 | |
29 Jan 24 | SellUS$182,345 | Cedric Francois | Individual | 2,843 | US$64.14 | |
29 Jan 24 | SellUS$56,057 | Pascal Deschatelets | Individual | 874 | US$64.14 | |
29 Jan 24 | SellUS$58,109 | Adam Townsend | Individual | 906 | US$64.14 | |
29 Jan 24 | SellUS$58,109 | David Watson | Individual | 906 | US$64.14 | |
29 Jan 24 | SellUS$53,555 | Nur Nicholson | Individual | 835 | US$64.14 | |
29 Jan 24 | SellUS$58,109 | Timothy Sullivan | Individual | 906 | US$64.14 | |
29 Jan 24 | SellUS$23,539 | Karen Lewis | Individual | 367 | US$64.14 | |
22 Jan 24 | SellUS$254,329 | Pascal Deschatelets | Individual | 3,913 | US$65.00 | |
22 Jan 24 | SellUS$221,831 | Adam Townsend | Individual | 3,413 | US$65.00 | |
22 Jan 24 | SellUS$271,943 | David Watson | Individual | 4,184 | US$65.00 | |
22 Jan 24 | SellUS$112,963 | Karen Lewis | Individual | 1,738 | US$65.00 | |
22 Jan 24 | SellUS$168,535 | Nur Nicholson | Individual | 2,593 | US$65.00 | |
22 Jan 24 | SellUS$230,801 | Timothy Sullivan | Individual | 3,551 | US$65.00 | |
22 Jan 24 | SellUS$89,954 | Mark Delong | Individual | 1,384 | US$65.00 | |
22 Jan 24 | SellUS$68,961 | James Chopas | Individual | 1,061 | US$65.00 | |
22 Jan 24 | SellUS$104,449 | Jeffrey Eisele | Individual | 1,607 | US$65.00 | |
22 Jan 24 | SellUS$872,961 | Cedric Francois | Individual | 13,431 | US$65.00 | |
16 Jan 24 | SellUS$524,514 | Cedric Francois | Individual | 7,851 | US$66.81 | |
16 Jan 24 | SellUS$109,032 | Karen Lewis | Individual | 1,632 | US$66.81 | |
16 Jan 24 | SellUS$149,317 | Timothy Sullivan | Individual | 2,235 | US$66.81 | |
16 Jan 24 | SellUS$124,064 | Nur Nicholson | Individual | 1,857 | US$66.81 | |
16 Jan 24 | SellUS$109,032 | Pascal Deschatelets | Individual | 1,632 | US$66.81 | |
16 Jan 24 | SellUS$149,317 | Adam Townsend | Individual | 2,235 | US$66.81 | |
16 Jan 24 | SellUS$283,268 | David Watson | Individual | 4,240 | US$66.81 | |
16 Jan 24 | SellUS$29,262 | Jeffrey Eisele | Individual | 438 | US$66.81 | |
16 Jan 24 | SellUS$108,965 | Mark Delong | Individual | 1,631 | US$66.81 | |
16 Jan 24 | SellUS$57,723 | James Chopas | Individual | 864 | US$66.81 | |
04 Jan 24 | SellUS$165,207 | Caroline Baumal | Individual | 2,751 | US$60.05 | |
26 Dec 23 | SellUS$3,935 | Jeffrey Eisele | Individual | 68 | US$57.86 | |
01 Dec 23 | SellUS$1,467,240 | Epidarex Capital | Company | 24,000 | US$61.14 | |
21 Nov 23 | SellUS$244,000 | Cedric Francois | Individual | 5,000 | US$48.80 | |
17 Nov 23 | SellUS$444,620 | A. Dunlop | Individual | 8,894 | US$49.99 | |
23 Oct 23 | SellUS$6,031 | Mark Delong | Individual | 131 | US$46.04 | |
23 Oct 23 | SellUS$6,077 | James Chopas | Individual | 132 | US$46.04 | |
17 Oct 23 | SellUS$1,176,000 | Epidarex Capital | Company | 24,000 | US$49.00 | |
18 Sep 23 | SellUS$490,589 | Nur Nicholson | Individual | 10,631 | US$46.15 | |
06 Sep 23 | SellUS$75,526 | Lukas Scheibler | Individual | 1,756 | US$43.01 | |
31 Aug 23 | SellUS$22,716 | James Chopas | Individual | 551 | US$41.23 |
내부자 거래량
내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.
소유권 분석
소유자 유형 | 공유 수 | 소유권 비율 |
---|---|---|
민간 기업 | 426 | 0.000322% |
주 또는 정부 | 45,130 | 0.0341% |
개인 내부자 | 4,344,854 | 3.29% |
VC/PE 기업 | 12,806,342 | 9.68% |
헤지 펀드 | 22,468,536 | 17% |
교육기관 | 92,568,574 | 70% |
주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 4.2% 만큼 증가했습니다.
최대 주주
소유권 | 이름 | 공유 | 현재 값 | 변경 % | 포트폴리오 % | |
---|---|---|---|---|---|---|
15,058,071 | US$603.4m | -8.44% | 0.09% | |||
12,806,342 | US$513.2m | 0% | 86.81% | |||
11,357,425 | US$455.1m | 1.65% | 14.29% | |||
11,111,111 | US$445.2m | 0% | 5.64% | |||
9,505,866 | US$380.9m | -0.52% | 0.01% | |||
7,064,967 | US$283.1m | -19.4% | 0.03% | |||
5,494,591 | US$220.2m | 2.11% | 데이터 없음 | |||
3,240,513 | US$129.8m | -1.08% | 0.08% | |||
2,909,528 | US$116.6m | -0.2% | 데이터 없음 | |||
2,806,980 | US$112.5m | 0% | 17.19% | |||
2,178,673 | US$87.3m | 4.12% | 0.01% | |||
2,131,400 | US$85.4m | -8.44% | 0.01% | |||
2,023,614 | US$81.1m | -5.66% | 0.17% | |||
1,834,224 | US$73.5m | -2.11% | 데이터 없음 | |||
1,726,000 | US$69.2m | 0% | 3.78% | |||
1,689,890 | US$67.7m | 3.63% | 0.01% | |||
1,593,606 | US$63.9m | 106% | 0.03% | |||
1,501,990 | US$60.2m | -49% | 0.01% | |||
1,315,282 | US$52.7m | -7.46% | 1.29% | |||
1,297,800 | US$52.0m | 40.7% | 0.76% | |||
1,186,082 | US$47.5m | 316% | 0.05% | |||
1,113,897 | US$44.6m | 2.48% | 데이터 없음 | |||
1,073,234 | US$43.0m | -20.2% | 0.03% | |||
1,054,440 | US$42.3m | 0.09% | 0.16% | |||
1,000,000 | US$40.1m | 0% | 1.17% |